Cargando…

Randomized Trial Comparing SGLT2 Inhibition and Hydrochlorothiazide on Sympathetic Traffic in Type 2 Diabetes

INTRODUCTION: Reductions in sympathetic nervous system activity may contribute to beneficial effects of sodium glucose cotransporter 2 (SGLT2) inhibition on cardiovascular outcomes. Therefore, we tested the hypothesis that SGLT2 inhibition with empagliflozin (Empa) lowers muscle sympathetic nerve ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heusser, Karsten, Tank, Jens, Diedrich, André, Fischer, Annelie, Heise, Tim, Jordan, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658269/ https://www.ncbi.nlm.nih.gov/pubmed/38025218 http://dx.doi.org/10.1016/j.ekir.2023.08.036

Ejemplares similares

Limited evidence for sympathetic neural overactivation in older patients with type 2 diabetes mellitus
por: Heusser, Karsten, et al.
Publicado: (2023)

Effect of Acute Ozone Induced Airway Inflammation on Human Sympathetic Nerve Traffic: A Randomized, Placebo Controlled, Crossover Study
por: Tank, Jens, et al.
Publicado: (2011)

Baroreflex Curve Fitting Using a WYSIWYG Boltzmann Sigmoidal Equation
por: Heusser, Karsten, et al.
Publicado: (2021)

Cardiac and Vascular Sympathetic Baroreflex Control during Orthostatic Pre-Syncope
por: Furlan, Raffaello, et al.
Publicado: (2019)

Endovascular baroreflex amplification and the effect on sympathetic nerve activity in patients with resistant hypertension: A proof-of-principle study
por: van Kleef, Monique E. A. M., et al.
Publicado: (2021)

Physiological Phenomenology of Neurally-Mediated Syncope with Management Implications
por: Schroeder, Christoph, et al.
Publicado: (2011)

Liver Afferents Contribute to Water Drinking-Induced Sympathetic Activation in Human Subjects: A Clinical Trial
por: May, Marcus, et al.
Publicado: (2011)

Cardiac pacemaker channel (HCN4) inhibition and atrial arrhythmogenesis after releasing cardiac sympathetic activation
por: Chobanyan-Jürgens, Kristine, et al.
Publicado: (2018)

Ultrafine particles and ozone perturb norepinephrine clearance rather than centrally generated sympathetic activity in humans
por: Heusser, Karsten, et al.
Publicado: (2019)

Testing individual baroreflex responses to hypoxia-induced peripheral chemoreflex stimulation
por: Kronsbein, Hendrik, et al.
Publicado: (2020)

Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High‐Fidelity Cardiovascular Phenotyping
por: Heusser, Karsten, et al.
Publicado: (2016)

Novel Approach to Elucidate Human Baroreflex Regulation at the Brainstem Level: Pharmacological Testing During fMRI
por: Gerlach, Darius A., et al.
Publicado: (2019)

Effects of Prolonged Head-Down Bed Rest on Cardiac and Vascular Baroreceptor Modulation and Orthostatic Tolerance in Healthy Individuals
por: Barbic, Franca, et al.
Publicado: (2019)

Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?
por: Verma, Subodh
Publicado: (2020)

Deciphering the neural signature of human cardiovascular regulation
por: Manuel, Jorge, et al.
Publicado: (2020)

The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition
por: Hædersdal, Sofie, et al.
Publicado: (2020)

Comparative antiplatelet effects of chlorthalidone and hydrochlorothiazide
por: Bashir, Khalid, et al.
Publicado: (2022)

Real‐Time Magnetic Resonance Imaging to Study Orthostatic Intolerance Mechanisms in Human Beings: Proof of Concept
por: Gerlach, Darius A., et al.
Publicado: (2022)

Effects of short-term hypercaloric nutrition on orthostatic tolerance in healthy individuals: a randomized controlled crossover study
por: De Gioannis, Riccardo, et al.
Publicado: (2022)

Sodium glucose cotransporter (SGLT)-2 inhibitors alleviate the renal stress responsible for sympathetic activation
por: Sano, Motoaki
Publicado: (2020)

Hydrochlorothiazide: Hypokalaemia: 2 case reports
Publicado: (2022)

A Systematic Review of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Sympathetic Nervous System Inhibition: An Underrated Mechanism of Cardiorenal Protection
por: Raza, Shafaat, et al.
Publicado: (2022)

Effects of SGLT2 inhibition on lipid transport in adipose tissue in type 2 diabetes
por: Lauritsen, Katrine M, et al.
Publicado: (2022)

Cerebral blood flow autoregulation assessment by correlation analysis between mean arterial blood pressure and transcranial doppler sonography or near infrared spectroscopy is different: A pilot study
por: Thudium, Marcus, et al.
Publicado: (2023)

Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study
por: Sharma, Arya M, et al.
Publicado: (2007)

Comparative Efficacy of Irbesartan/ Hydrochlorothiazide and Valsartan/Hydrochlorothiazide Combination in Lowering Blood Pressure: A Retrospective Observational Study in Oman
por: Al Balushi, K.A., et al.
Publicado: (2013)

Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide—meta-analysis
por: Dineva, Stela, et al.
Publicado: (2019)

Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?
por: Pitt, Bertram, et al.
Publicado: (2022)

Nephroprotection by SGLT2 Inhibition: Back to the Future?
por: De Nicola, Luca, et al.
Publicado: (2020)

Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension
por: Marfatia, Ravi, et al.
Publicado: (2012)

Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF
por: Bode, David, et al.
Publicado: (2021)

Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients
por: Destro, Maurizio, et al.
Publicado: (2010)

Preserved functional autonomic phenotype in adult mice overexpressing moderate levels of human alpha‐synuclein in oligodendrocytes
por: Tank, Jens, et al.
Publicado: (2014)

A Comparative Study of the Management of Stage 2 hypertension by Combined therapy with Losartan, Amlodipine and Hydrochlorothiazide
por: Jafarzadeh Esfehani, Reza, et al.
Publicado: (2012)

Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis
por: Kalra, Sanjay, et al.
Publicado: (2015)

SGLT2 inhibition reduces myocardial oxygen consumption
por: Søndergaard, Esben, et al.
Publicado: (2022)

Telmisartan/hydrochlorothiazide-induced hepatotoxicity
por: Lorena, Marco, et al.
Publicado: (2015)

Hydrochlorothiazide: Hypocalcaemia: case report
Publicado: (2020)

SGLT2 and cancer
por: Wright, Ernest M.
Publicado: (2020)

Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
por: Sureshkumar, Kalathil K
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_t0br8cu863ksuvgic41ti216n1